On June 29, Axinn partner Jason Murata spoke at ACI's 13th Summit on Biosimilars & Innovator Biologics held June 28-29 in Boston.

Jason Murata spoke on a panel entitled, "Advocating for Diversity in IP: Practical Ideas for Implementing Change.” Panelists discussed growing the awareness of pharmaceutical IP practitioners among underrepresented racial and ethnic groups, accelerating the advancement of a more diverse pharmaceutical IP community, and implementing organizational changes that promote diversity.

Click here for more information, including how to register.